We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This series brings together all documents relating to HMT DAO letters
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Employment Appeal Tribunal Judgment of Judge Auerbach on 28 March 2024.
Employment Appeal Tribunal Judgment of Lord Fairley on 18 April 2024.
Statement follows the eighth meeting of the UK - U.S. SME Dialogues in Belfast, Northern Ireland.
Documents, certificate, letters, and notes available from the British embassy and consulates in the USA.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 April 2024.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Joint Press Statement by the Permanent Representatives of the United States, Albania, Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Cyprus, Czechia, Denmark, Ecuador, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Moldova, Monaco,...
This guidance describes case definitions to inform testing and reporting of suspected mpox cases.
Check the tariff classification for oilcake and other residues resulting from the extraction of olive oil.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Check the tariff classification for peptide nisin standardised with sodium chloride
This guidance provides information on important security and political risks which UK businesses may face when operating in Japan.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Information on how UK companies can control risks when doing business in Mexico.
The Charity Commission has launched a statutory inquiry following concerns over how charitable funds have been used by a now sanctioned individual.
Use a separate statement of objection form for each Japanese GI product name you object to.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.